pALD Lenti Protocol and Sequence Request

Confidential Disclosure Agreement

These sequences and the protocol, specifically the ratios of the plasmids, are intellectual property owned by Oxgene for use by Aldevron and Aldevron’s clients. This information may be transferred to vendors for the sole purpose of performing work on your behalf and with whom you have a confidentiality agreement. You must identify this information as confidential and subject to the confidentiality agreement and you must email dnaproducts@aldevron.com with the name of the company to whom you disclosed this information. Any other transfer of this information is prohibited. We may notify Oxgene that you have requested this information but no other information will be transferred.

By completing this form you agree to keep this information confidential and treat it with the same care and regard as confidential information of your organization. If you do not agree to the terms outlined on this page, do not complete this form. The confidentiality and disclosure obligations you accept by completing this form are in addition to any confidentiality agreement you have with Aldevron. When completing this form, please use a business email address.

Request pALD Lenti documentation

region na1
portalId 1769030
formId 536c791f-fc75-440f-a027-6f8c2cbd325b
target services-hubspot-form